Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
162M
-
Number of holders
-
246
-
Total 13F shares, excl. options
-
161M
-
Shares change
-
-3.87M
-
Total reported value, excl. options
-
$1.55B
-
Value change
-
-$46.1M
-
Put/Call ratio
-
0.84
-
Number of buys
-
108
-
Number of sells
-
-135
-
Price
-
$9.63
Significant Holders of IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) as of Q3 2023
291 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK as of Q3 2023.
IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) has 246 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 161M shares
of 162M outstanding shares and own 99.74% of the company stock.
Largest 10 shareholders include BlackRock Inc. (25.2M shares), Sarissa Capital Management LP (16.4M shares), VANGUARD GROUP INC (14.9M shares), STATE STREET CORP (12M shares), LSV ASSET MANAGEMENT (7.16M shares), RENAISSANCE TECHNOLOGIES LLC (5.8M shares), DIMENSIONAL FUND ADVISORS LP (5.52M shares), CREDIT SUISSE AG/ (4.5M shares), VICTORY CAPITAL MANAGEMENT INC (4.41M shares), and BROWN CAPITAL MANAGEMENT LLC (3.72M shares).
This table shows the top 246 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.